- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ho Chi Minh City Vietnam
- IPO Date
- Jul 13, 2018
- Business
- Codupha Central Pharmaceutical Joint Stock Company is a Vietnam-based healthcare and pharmaceutical distribution enterprise primarily engaged in the import, export, warehousing, wholesale distribution, and retail commercialization of pharmaceutical products, active medical supplies, and healthcare equipment. Founded in 1975 and headquartered in Ho Chi Minh City, Vietnam, the company operates as an operating affiliate of the state-backed Vietnam Pharmaceutical Corporation (Vinapharm). The company conducts business operations across multiple commercial segments, including Ethical Pharmaceuticals (ETC), Over-the-Counter Healthcare (OTC), Medical Equipment and Consumables, and Specialized Supply Chain Services. Its systematic product and service offerings comprise prescription medications spanning critical therapeutic categories such as cardiovascular treatments, systemic antibiotics, oncological drugs, gastrointestinal agents, respiratory therapies, analgesics, and central nervous system medicines; over-the-counter pharmaceuticals, traditional herbal remedies, and dermatological products; nutritional supplements, vitamins, functional foods, and health beverages; medical devices, surgical instruments, diagnostic reagents, hospital consumables, and personal protective supplies; and third-party healthcare logistics services, including Good Storage Practice (GSP) and Good Distribution Practice (GDP) compliant cold-chain warehousing, customs brokerage, regulatory registration support, inventory management, and nationwide temperature-controlled freight distribution. The company serves public and private hospitals, provincial medical centers, clinical laboratories, retail pharmacy chains, and independent drugstores throughout Vietnam through regional distribution hubs and branch facilities located in Ho Chi Minh City, Hanoi, Da Nang, and Can Tho. In recent operational and strategic developments, Codupha Central Pharmaceutical Joint Stock Company has expanded its GDP- and GSP-standard cold-chain storage infrastructure to accommodate increased import volumes of temperature-sensitive biologic therapies and specialized specialty medications; broadened strategic distribution partnerships with multinational pharmaceutical manufacturers to expand its tender bidding portfolio across tertiary hospital networks; implemented modernized digital warehouse management and enterprise resource planning systems to optimize supply chain visibility and hospital tender fulfillment; and restructured its commercial sales divisions to accelerate expansion into modern retail pharmacy chains and sub-distributor networks across Vietnam.